€2.54
0.52%
L&S, Jun 28, 10:54 pm CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2024 - Analyst rating & recommendation

JD Health International Classifications & Recommendation:

Buy
80%
Hold
15%
Sell
5%

JD Health International Target price

Target price HKD42.04
Course HKD21.25
Price potential
Number of estimates 17
17 Analysts have issued a price target JD Health International 2025 . The average JD Health International target price is HKD42.04. This is higher than the current share price. The highest price target is
HKD79.22 272.82%
register free of charge
, the lowest is .
A rating was issued by 20 analysts: 16 Analysts recommend JD Health International to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the JD Health International share has an average upside potential 2025 of . Most analysts recommend the JD Health International share at Purchase.

Sales and margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Turnover Billion HKD 59.15 66.62
8.84% 12.62%
EBITDA margin 1.60% 2.81%
16,955.58% 75.25%
Net margin 4.10% 4.03%
398.79% 1.63%

19 Analysts have issued a sales forecast JD Health International 2024 . The average JD Health International sales estimate is

HKD66.6b
unlock
. This is
12.52% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
HKD68.0b 14.87%
unlock
, the lowest is
HKD62.2b 5.07%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 HKD59.2b 8.84%
2024
HKD66.6b 12.62%
unlock
2025
HKD77.9b 16.91%
unlock
2026
HKD89.5b 14.90%
unlock

10 Analysts have issued an JD Health International EBITDA forecast 2024. The average JD Health International EBITDA estimate is

HKD1.9b
unlock
. This is
91.30% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD2.1b 110.73%
unlock
, the lowest is
HKD1.5b 53.80%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 HKD948m 18,444.87%
2024
HKD1.9b 97.11%
unlock
2025
HKD2.8b 52.21%
unlock
2026
HKD3.9b 37.29%
unlock

EBITDA margin

2023 1.60% 16,955.58%
2024
2.81% 75.25%
unlock
2025
3.65% 29.89%
unlock
2026
4.37% 19.73%
unlock

10 JD Health International Analysts have issued a net profit forecast 2024. The average JD Health International net profit estimate is

HKD2.7b
unlock
. This is
10.83% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD3.1b 28.69%
unlock
, the lowest is
HKD2.3b 6.38%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 HKD2.4b 442.86%
2024
HKD2.7b 10.83%
unlock
2025
HKD3.5b 31.26%
unlock
2026
HKD4.4b 25.79%
unlock

Net margin

2023 4.10% 398.79%
2024
4.03% 1.63%
unlock
2025
4.53% 12.41%
unlock
2026
4.96% 9.49%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Earnings per share HKD 0.76 0.84
442.86% 10.53%
P/E ratio 25.23
EV/Sales 0.34

10 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International <a href=/blog/eps>EPS is

HKD0.84
unlock
. This is
10.53% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
HKD0.98 28.95%
unlock
, the lowest is
HKD0.71 6.58%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 HKD0.76 442.86%
2024
HKD0.84 10.53%
unlock
2025
HKD1.11 32.14%
unlock
2026
HKD1.39 25.23%
unlock

P/E ratio

Current 27.87 91.60%
2024
25.23 9.47%
unlock
2025
19.22 23.82%
unlock
2026
15.28 20.50%
unlock

Based on analysts' sales estimates for 2024, the JD Health International share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 0.38 79.12%
2024
0.34 10.61%
unlock
2025
0.29 14.45%
unlock
2026
0.25 12.97%
unlock

P/S ratio

Current 1.14 58.99%
2024
1.02 11.13%
unlock
2025
0.87 14.46%
unlock
2026
0.76 12.97%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now